Join the 200th Anniversary Celebration

Correction

A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis

N Engl J Med 2002; 347:862September 12, 2002

Article

A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis (Original Article, N Engl J Med 2002:346;1119 - 1126) . The Appendix on page 1125 should have included Peter McCluskey (St. Vincent's Hospital, Sydney, Australia) as a member of the Valganciclovir Study Group.